HIGHLIGHTS
- who: Julie Egea and collaborators from the Department of Medical Oncology, Institut de Cancu00e9rologie de Lorraine, Vandu0153uvre-lu00e8s-Nancy, France have published the research: Development of a Clinical-Biological Model to Assess Tumor Progression in Metastatic Pancreatic Cancer: Post Hoc Analysis of the PRODIGE4/ACCORD11 Trial, in the Journal: Cancers 2022, 14, 5068. https:// of 30/08/2022
- what: The authors aimed to establish a clinical-biological model to highlight the progression of metastatic PC during first-line treatment. Since no predictive markers are available that can determine progression on their own, the authors aimed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.